05.23.25 -- Find Your CDMO For Biologic API & Drug Product Manufacturing

To assist customers in developing a comprehensive, risk-based approach to the evaluation of extractables and leachables, West has developed a robust Materials Characterization extractables data package for elastomer 4031/45 Gray.

Leverage Aragen's clinically relevant pulmonary fibrosis models to accelerate your drug discovery efforts and enhance your Idiopathic pulmonary fibrosis (IPF) drug development pipeline.

Singota Solutions specializes in small volume jobs needing quick turnaround including those with demanding specifications, customized requirements, and manually intensive procedures which avoids tooling and expensive set-up costs.

Review the extensive contract manufacturing capabilities of Novartis, with a focus on tech transfer, clinical drug substance production, and commercial drug substance manufacturing.

ReciBioPharm GMP manufacturing units focus on process robustness and consistency to ensure product quality, purity and efficacy. Our multi-product manufacturing facilities feature equipment for animal cell-derived viral and microbial products.

We use our bio-logic brilliance to unravel the complexities of ADCs — empowering companies to accelerate development, enhance manufacturing efficiency, and deliver life-changing therapies.

You can count on Simtra's extensive scientific and manufacturing expertise, stringent quality standards, and highly responsive customer service to ensure timely delivery of your products.

The addition of global sterile fill/finish and extensive lyophilization capabilities ensures that we are able to build on our enviable reputation and deliver on our promise of delivering life-changing therapies to patients worldwide.

Business Head of Biologics and Vaccines Evan Pasenello shares how Resilience’s innovative platforms and specialized expertise can effectively support your development and manufacturing programs.

Samsung Biologics offers end-to-end solutions taking your molecule seamlessly from sequence to IND. Utilizing advanced technical platforms and knowledge, and diverse, flexible capacity, you can reduce the time and costs of biologic development.

Working with SGS can help address capacity limitations, decrease overhead costs, and allow production when in-house capabilities are restricted. Get to market quickly, safely, and efficiently.